About: BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.12 (-2.10%)
BLSM NASDAQ BlossomHill Therapeutics, Inc. Common Stock
BlossomHill Therapeutics, Inc. Common Stock share price
BLSM price activity
Last Price
$12.120
Change (24hr)
-0.26 USD (2.10%)
Volume
75.75K
Volume (4w avg)
-
Open
$12.30
Day Range
$11.02 - $13.03
Previous Close
$12.38
Last Trade
05 Nov, 3:32 pm GMT+0
Delayed
05 Nov, 3:32 pm GMT+0
BLSM price performance
Delayed
05 Nov, 3:32 pm GMT+0
BLSM details
BLSM Market Signals